Global Neglected Tropical Disease (NTD) Treatment Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2028
Global Neglected Tropical Disease (NTD) Treatment Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2028
The Neglected Tropical Disease (NTD) Treatment study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and parasitic worms (helminths).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period.
Data collected includes market dynamics, technology outlook, application development, and pricing trends. All of this is fed into a research model, which then produces relevant data for market research. Global market trend analysis is given including historical data, estimates to 2023 and compound annual growth rate (CAGR) forecast to 2028.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
2023 will be a tough year for much of the global economy, as the ongoing war in Ukraine continues to strain trade, especially in Europe, and the global economy remains reeling from the fallout from the COVID-19 pandemic.
But as China moves ever closer to fully reemerging from three years of government-imposed Covid isolation and reintegrating with the world, economic expectations are high.And with the global economy now facing significant challenges, including energy shortages, slowing growth and high inflation, China’s reopening could provide a much-needed and timely boost.
The report researches and analyzes the influence of the Neglected Tropical Disease (NTD) Treatment industry in the new era of global post-COIVD-19 economy in 2023, and provides in-depth analysis and professional suggestions on the current development.
Market Segment by Product Type
Drugs
Vaccines
Market Segment by Product Application
Hospitals and Clinics
Diagnostic Centers
Academic and Research Organizations
Finally, the report provides detailed profile and data information analysis of leading company.
F. Hoffmann-La Roche
Bayer
GlaxoSmithKline
Novartis
Pfizer
Eisai
Sanofi
Astellas Pharma
Takeda Pharmaceutical Company
Gilead Sciences
Insights and Tools:
We follow a comprehensive process to estimate market size. Key industry dynamics, regulatory scenarios, and segmental dynamics are analyzed to understand their impact on demand over the forecast period. Macroeconomic indicators such as prices, income and demographic changes, demand changes, etc. are considered in estimating market size. We also provide an in-depth profile of the key players and discuss their market shares in the global market to derive the market value. In addition, we have an internal database that is regularly updated with key insights and press releases from key stakeholders in the relevant market.
The data is generally gathered in various arrangements such as charts, graphs, infographics, trends, documents and records from various manufacturers and retailers. Our analyst gather, collect, and interpret such data to form significant databases. Our team then works with large data volumes to analyze core developments, evaluate market estimations, and identify trends.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To study and analyze the global Neglected Tropical Disease (NTD) Treatment consumption (value) by key regions/countries, product type and application, history data from 2018 to 2022, and forecast to 2028.
2.To understand the structure of Neglected Tropical Disease (NTD) Treatment market by identifying its various subsegments.
3.Focuses on the key global Neglected Tropical Disease (NTD) Treatment manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Neglected Tropical Disease (NTD) Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Neglected Tropical Disease (NTD) Treatment submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Global Neglected Tropical Disease (NTD) Treatment Market Research Report 2023, Forecast to 2028
1 Market Study Overview
1.1 Study Objectives
1.2 Neglected Tropical Disease (NTD) Treatment Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Neglected Tropical Disease (NTD) Treatment Segment by Type
2.1.1 Drugs
2.1.2 Vaccines
2.2 Market Analysis by Application
2.2.1 Hospitals and Clinics
2.2.2 Diagnostic Centers
2.2.3 Academic and Research Organizations
2.3 Global Neglected Tropical Disease (NTD) Treatment Market Comparison by Regions (2018-2028)
2.3.1 Global Neglected Tropical Disease (NTD) Treatment Market Size (2018-2028)
2.3.2 North America Neglected Tropical Disease (NTD) Treatment Status and Prospect (2018-2028)
2.3.3 Europe Neglected Tropical Disease (NTD) Treatment Status and Prospect (2018-2028)
2.3.4 China Neglected Tropical Disease (NTD) Treatment Status and Prospect (2018-2028)
2.3.5 Japan Neglected Tropical Disease (NTD) Treatment Status and Prospect (2018-2028)
2.3.6 Southeast Asia Neglected Tropical Disease (NTD) Treatment Status and Prospect (2018-2028)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Neglected Tropical Disease (NTD) Treatment Industry Impact
2.5.1 Neglected Tropical Disease (NTD) Treatment Business Impact Assessment - Covid-19
2.5.2 Market Trends and Neglected Tropical Disease (NTD) Treatment Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Neglected Tropical Disease (NTD) Treatment Sales and Market Share by Manufacturer (2018-2023)
3.2 Global Neglected Tropical Disease (NTD) Treatment Revenue and Market Share by Manufacturer (2018-2023)
3.3 Global Neglected Tropical Disease (NTD) Treatment Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Neglected Tropical Disease (NTD) Treatment Manufacturer Market Share
3.5 Top 10 Neglected Tropical Disease (NTD) Treatment Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Neglected Tropical Disease (NTD) Treatment Market
3.7 Key Manufacturers Neglected Tropical Disease (NTD) Treatment Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Neglected Tropical Disease (NTD) Treatment Industry Key Manufacturers
4.1 F. Hoffmann-La Roche
4.1.1 Compan Detail
4.1.2 F. Hoffmann-La Roche Neglected Tropical Disease (NTD) Treatment Product Introduction, Application and Specification
4.1.3 F. Hoffmann-La Roche 133 Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.1.4 Main Business Overview
4.1.5 F. Hoffmann-La Roche News
4.2 Bayer
4.2.1 Compan Detail
4.2.2 Bayer Neglected Tropical Disease (NTD) Treatment Product Introduction, Application and Specification
4.2.3 Bayer Neglected Tropical Disease (NTD) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.2.4 Main Business Overview
4.2.5 F. Hoffmann-La Roche News
4.3 GlaxoSmithKline
4.3.1 Compan Detail
4.3.2 GlaxoSmithKline Neglected Tropical Disease (NTD) Treatment Product Introduction, Application and Specification
4.3.3 GlaxoSmithKline Neglected Tropical Disease (NTD) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.3.4 Main Business Overview
4.3.5 GlaxoSmithKline News
4.4 Novartis
4.4.1 Compan Detail
4.4.2 Novartis Neglected Tropical Disease (NTD) Treatment Product Introduction, Application and Specification
4.4.3 Novartis Neglected Tropical Disease (NTD) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.4.4 Main Business Overview
4.4.5 Novartis News
4.5 Pfizer
4.5.1 Compan Detail
4.5.2 Novartis Neglected Tropical Disease (NTD) Treatment Product Introduction, Application and Specification
4.5.3 Pfizer Neglected Tropical Disease (NTD) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.5.4 Main Business Overview
4.5.5 Pfizer News
4.6 Eisai
4.6.1 Compan Detail
4.6.2 Eisai Neglected Tropical Disease (NTD) Treatment Product Introduction, Application and Specification
4.6.3 Eisai Neglected Tropical Disease (NTD) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.6.4 Main Business Overview
4.6.5 Eisai News
4.7 Sanofi
4.7.1 Compan Detail
4.7.2 Sanofi Neglected Tropical Disease (NTD) Treatment Product Introduction, Application and Specification
4.7.3 Sanofi Neglected Tropical Disease (NTD) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Astellas Pharma
4.8.1 Compan Detail
4.8.2 Astellas Pharma Neglected Tropical Disease (NTD) Treatment Product Introduction, Application and Specification
4.8.3 Astellas Pharma Neglected Tropical Disease (NTD) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.8.4 Main Business Overview
4.8.5 Astellas Pharma News
4.9 Takeda Pharmaceutical Company
4.9.1 Compan Detail
4.9.2 Takeda Pharmaceutical Company Neglected Tropical Disease (NTD) Treatment Product Introduction, Application and Specification
4.9.3 Takeda Pharmaceutical Company Neglected Tropical Disease (NTD) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.9.4 Main Business Overview
4.9.5 Takeda Pharmaceutical Company News
4.10 Gilead Sciences
4.10.1 Compan Detail
4.10.2 Gilead Sciences Neglected Tropical Disease (NTD) Treatment Product Introduction, Application and Specification
4.10.3 Gilead Sciences Neglected Tropical Disease (NTD) Treatment Sales, Price, Cost, Gross Margin, and Revenue (2018-2023)
4.10.4 Main Business Overview
4.10.5 Gilead Sciences News
5 Global Neglected Tropical Disease (NTD) Treatment Market Segment by Big Type
5.1 Global Neglected Tropical Disease (NTD) Treatment Revenue, Sales and Market Share by Big Type (2018-2023)
5.1.1 Global Neglected Tropical Disease (NTD) Treatment Sales and Market Share by Big Type (2018-2023)
5.1.2 Global Neglected Tropical Disease (NTD) Treatment Revenue and Market Share by Big Type (2018-2023)
5.2 Drugs Sales Growth Rate and Price
5.2.1 Global Drugs Sales Growth Rate (2018-2023)
5.2.2 Global Drugs Price (2018-2023)
5.3 Vaccines Sales Growth Rate and Price
5.3.1 Global Vaccines Sales Growth Rate (2018-2023)
5.3.2 Global Vaccines Price (2018-2023)
6 Global Neglected Tropical Disease (NTD) Treatment Market Segment by Big Application
6.1 Global Neglected Tropical Disease (NTD) Treatment Sales Market Share by Big Application (2018-2023)
6.2 Hospitals and Clinics Sales Growth Rate (2018-2023)
6.3 Diagnostic Centers Sales Growth Rate (2018-2023)
6.4 Academic and Research Organizations Sales Growth Rate (2018-2023)
7 Global Neglected Tropical Disease (NTD) Treatment Forecast
7.1 Global Neglected Tropical Disease (NTD) Treatment Revenue, Sales and Growth Rate (2023-2028)
7.2 Neglected Tropical Disease (NTD) Treatment Market Forecast by Regions (2023-2028)
7.2.1 North America Neglected Tropical Disease (NTD) Treatment Market Forecast (2023-2028)
7.2.2 Europe Neglected Tropical Disease (NTD) Treatment Market Forecast (2023-2028)
7.2.3 China Neglected Tropical Disease (NTD) Treatment Market Forecast (2023-2028)
7.2.4 Japan Neglected Tropical Disease (NTD) Treatment Market Forecast (2023-2028)
7.2.5 Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Forecast (2023-2028)
7.2.6 Other Regions Neglected Tropical Disease (NTD) Treatment Market Forecast (2023-2028)
7.3 Neglected Tropical Disease (NTD) Treatment Market Forecast by Type (2023-2028)
7.3.1 Global Neglected Tropical Disease (NTD) Treatment Sales Forecast by Type (2023-2028)
7.3.2 Global Neglected Tropical Disease (NTD) Treatment Market Share Forecast by Type (2023-2028)
7.4 Neglected Tropical Disease (NTD) Treatment Market Forecast by Application (2023-2028)
7.4.1 Global Neglected Tropical Disease (NTD) Treatment Sales Forecast by Application (2023-2028)
7.4.2 Global Neglected Tropical Disease (NTD) Treatment Market Share Forecast by Application (2023-2028)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Neglected Tropical Disease (NTD) Treatment Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Neglected Tropical Disease (NTD) Treatment Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
Tables & Figures:
F. Hoffmann-La Roche
Bayer
GlaxoSmithKline
Novartis
Pfizer
Eisai
Sanofi
Astellas Pharma
Research Methodology:
Neglected Tropical Disease (NTD) Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|